☆ 4.7 Article

The oral hypoxia-inducible factor prolyl hydroxylase inhibitor enarodustat counteracts alterations in renal energy metabolism in the early stages of diabetic disease

KIDNEY INTERNATIONAL (2020)

Get Full Text
Add to Collection

Journal

KIDNEY INTERNATIONAL
Volume 97, Issue 5, Pages 934-950

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.kint.2019.12.007

Keywords

-

Categories

Urology & Nephrology

Funding

  1. Isotope Science Center, the University of Tokyo
  2. JSPS KAKENHI grant [19J11928, 18H02824, 17K09688]
  3. KAKENHI [26111003]
  4. Grants-in-Aid for Scientific Research [18H02824, 19J11928, 17K09688] Funding Source: KAKEN

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.